Compound ID | 2975
T9W
Class: Antimicrobial peptide
| Agent Type: | Synthetic; Direct acting; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Membrane-active agent. Binds to lipopolysaccharide to disrupt and depolarize cell membrane) |
| Target Pathogen: | Active against Pseudomonas aeruginosa (including strains resistant to gentamicin, ceftazidime, and ciprofloxacin) |
| Description: | Synthetic compound; an 𝛼-helical antimicrobial peptide; shows synergistic activity effect with gentamicin and ciprofloxacin; cytotoxicity (10% viability reduction) towards macrophage cells at 290 ug/ml vs MIC at 2-4 ug/ml |
| Year first mentioned: | 2015 |
| Development status: | Experimental |
| External links: | |
| Citation: | https://journals.asm.org/doi/10.1128/aac.04830-14 |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.